Carotid web–associated stroke in a middle-aged woman on tibolone: a hidden cause of large vessel occlusion
Abstract
Case Presentation: A 54-year-old previously healthy woman presented with hyperacute aphasia and complete right hemiparesis, with symptom onset 1 hour and 50 minutes before admission. Neurological examination revealed NIHSS 8 and ASPECTS 8. Computed tomography angiography demonstrated occlusion of the proximal M1 segment of the left middle cerebral artery. Intravenous thrombolysis with alteplase was administered, followed by mechanical thrombectomy. Endovascular treatment with a 4×40 mm Solitaire® stent retriever using a single-pass technique under balloon guide catheter (Cello®) occlusion and aspiration achieved near-complete reperfusion (TICI 2C). A carotid web was identified in the left internal carotid artery, just distal to the bifurcation. No hemorrhagic transformation was observed. Etiological workup was unremarkable. The patient had no vascular risk factors and had been using oral tibolone for four months. At 5 days, she showed near-complete recovery, with minimal residual deficit. Rivaroxaban was initiated Discussion: Acute ischemic stroke is a time-sensitive condition in which rapid reperfusion directly influences functional outcomes. Determining etiology is essential for guiding secondary prevention. Nonatherosclerotic causes are increasingly recognized, particularly in younger individuals. Carotid web is an underrecognized vascular abnormality characterized by a shelf-like intimal projection at the carotid bulb, leading to flow disturbance, turbulence, and local stasis. These changes predispose to thrombus formation and artery-to-artery embolization and have been identified in up to 10–20% of cryptogenic strokes. Estrogen exposure promotes a prothrombotic state by increasing procoagulant factors and reducing endogenous anticoagulant activity. In patients with carotid web, this may further increase embolic risk. This interaction may be particularly relevant in individuals without traditional vascular risk factors. Observational data report recurrence rates of 15–30% within 2–5 years with medical therapy alone. Interventional strategies may reduce recurrence, but evidence remains limited and no consensus guidelines exist. Anticoagulation was chosen, considering a likely thromboembolic mechanism, with future intervention if recurrence occurs. Final Comments: A significant proportion of ischemic strokes are cryptogenic, especially in younger patients. In this group, etiological investigation should include non-atherosclerotic causes such as carotid web. Although rare, it carries a high risk of recurrence and lacks a well-defined treatment strategy. Prospective randomized studies are needed to guide secondary prevention and improve long-term outcomes.